SureTrader Advertisement
Home > Boards > US Listed > Biotechs > NorthWest Biotherapeutics (NWBO)

Here is the link to Germany DCVax Clinical

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
john1045 Member Profile
 
Followed By 30
Posts 2,141
Boards Moderated 0
Alias Born 06/09/11
160x600 placeholder
Pre-Market Review on Biotechnology Equities -- Northwest Biotherapeutics, Titan Pharma, Ultragenyx Pharma, and Athersys "PR Newswire (US)" - 6/29/2016 8:30:00 AM
NW Bio Announces Scientific Advisory Board "PR Newswire (US)" - 6/13/2016 9:15:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 5/19/2016 9:26:04 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/11/2016 6:05:17 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 5/10/2016 5:49:20 PM
These Four Small Caps Are on Our Radar This Week "InvestorsHub NewsWire" - 5/4/2016 7:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/3/2016 9:05:07 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 5/3/2016 6:05:17 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/2/2016 5:25:44 PM
NW Bio Announces Operations Updates "PR Newswire (US)" - 5/2/2016 5:00:00 PM
Amended Annual Report (10-k/a) "Edgar (US Regulatory)" - 4/29/2016 6:10:06 PM
Broad Street Alerts Issues Watch List and Due Diligence Report’s "InvestorsHub NewsWire" - 4/19/2016 8:10:00 AM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 3/16/2016 3:47:34 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 3/15/2016 4:29:20 PM
Amended Statement of Beneficial Ownership (sc 13d/a) "Edgar (US Regulatory)" - 3/15/2016 2:32:33 PM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 3/15/2016 6:05:08 AM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 3/8/2016 5:42:22 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/3/2016 2:48:01 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 3/3/2016 8:51:07 AM
NW BIO Announces Registered Direct Offering Of Up To $27.6 Million With Existing Institutional Investors "PR Newswire (US)" - 2/29/2016 10:58:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/27/2016 5:02:18 PM
NW Bio Announces Appointment Of Two New Independent Directors With Biotech/Pharma Expertise and Cybersecurity/Investigations ... "PR Newswire (US)" - 1/25/2016 9:30:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 1/12/2016 5:07:45 PM
NW Bio Issues Statement on Adverse Market Conditions And NW Bio Stock Decline "PR Newswire (US)" - 1/8/2016 9:15:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 12/30/2015 5:28:32 PM
john1045   Monday, 12/24/12 04:47:16 PM
Re: None
Post # of 65819 
Here is the link to Germany DCVax Clinical trials with an area I pasted from long report so they obviously are recruiting over there as of now....

http://translate.google.com/translate?hl=en&sl=de&u=http://www.uniklinik-duesseldorf.de/fileadmin/Datenpool/einrichtungen/universitaetstumorzentrum_id505/neu2012/Dateien/Klinische_Studien_UTZ_Duesseldorf.pdf&prev=/search%3Fq%3Ddcvax%26start%3D50%26hl%3Den%26sa%3DN%26tbo%3Dd%26biw%3D1366%26bih%3D586%26tbs%3Dqdr:w&sa=X&ei=I8nYULiqM7GH0QGx6oDACg&ved=0CGwQ7gEwCTgy

Page 11 of 23

Clinical trials in brain tumors


IND No. 10206

Glioblastoma (brain cancer)

Phase II clinical trial to evaluate DCVax-Brain, autologous dendritic cells pulsed with tumor lysate, for treatment

of glioblastoma multiforme.



A Phase II Clinical Trial Evaluating DCVax-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate for the Treatment of Glioblastoma

Multiforme

Your contact:

Prof. Dr. Michael Sabel

Michael.Sabel @ med.uni-duesseldorf.de



Page 12


Current clinical studies at University Cancer Center UTZ

University Cancer Center UTZ

Info Phone: 0211-8108200

at the University Hospital Dusseldorf

www.uniklinik-duesseldorf.de/utz

Stand: 01/2013

Page 12 of 23

Clinical trials in brain tumors

Fraunhofer Institute

Glioblastoma (brain cancer)

Phase II clinical study evaluating DCVax ®-L Brain autologous dendritic cells loaded with tumor lysate antigen for

Treatment of glioblastoma multiforme (GBM)

Clinical phase II trial to evaluate DCVax ®-L Brain autologous dendritic cells loaded with tumor lysate antigen for treatment of glioblastoma

multiforme (GBM)

Your contact:

Infoline

Tel: 0211-8108200

uta@med.uni-duesseldorf.de


SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist